Wall Street Pulls Back After Major Rally

US stocks were set for a downbeat session Thursday as markets took a breather following a major rally in the previous session after Federal Reserve Chair Jerome Powell eased worries about monetary tightening.

Oil prices nudged higher with global benchmark Brent crude up 1.24%, and US West Texas Intermediate crude up 2% recently despite persistent concerns about oversupply.

Data released at 8:30 am showed new unemployment claims jumped 10,000, vs estimates for a 4,000 decline, to 234,000 in the Nov. 24 week. Personal income, consumer spending and the PCE price index rose 0.5%, 0.6%, and 0.2%, respectively, in October vs estimates for gains of 0.4%, 0.4%, and 0.2%, according to data compiled by Econoday.

At 10 am, pending home sales are expected to remain unchanged in October after a 0.5% rise in the previous month.

In equities, shares of Abercrombie & Fitch ( ANF ) were trading 19.1% higher pre-bell after it reported Q3 profit that topped Street expectations.


-Dow Jones Industrial down 0.03%

-S&P 500 futures down 0.17%

-Nasdaq 100 futures down 0.34%

-Nasdaq 100 pre-market indicator down 0.14%


Nikkei up 0.39%

Hang Seng down 0.87%

Shanghai Composite down 1.32%

FTSE-100 up 0.68%

DAX-30 up 0.45%


(-) Large cap tech: unchanged to lower

(-) Chip stocks: unchanged to lower

(-) Software stocks: unchanged to lower

(-) Hardware stocks: unchanged to lower

(-) Internet stocks: unchanged to lower

(+/-) Oil stocks: mixed

(+/-) Biotech stocks: unchanged

(-) Drug stocks: unchanged to lower

(+/-) Financial stocks: unchanged

(-) Retail stocks: unchanged to lower

(-) Industrial stocks: unchanged to lower

(-) Airlines: unchanged to lower

(-) Autos: unchanged to lower


(+) TNXP (+65.1%) Reports details of new phase 3 study of Tonmya for PTSD

(+) NLSN (+5.4%) Horizon Media adopts Nielsen digital content ratings

(+) RSLS (+9%) Secures $25 million financing


(-) DB (-3.5%) Co.'s HQ raided as part of Panama paper probe

(-) CPRX (-2.9%) FDA approves Firdapse for the treatment of Lambert-Eaton Myasthenic Syndrome

(-) ATO (-3.8%) Prices stock offering at $92.75

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 All rights reserved. Unauthorized reproduction is strictly prohibited.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More